Cell Culture Technology– category –
-
Viral Vectors: Wave-mixed vs stirred-tank bioreactor specs
BioProcess Tools USA Overview A comparative analysis of bioreactor platforms for viral vector manufacturing reveals distinct advantages: wave-mixed bioreactors, offering low shear, are ideal for shear-sensitive lentivirus, T-cell expansi... -
CYBORGEL: UC Davis $36.5M ARPA-H cell therapy storage timeline
University of California, Davis USA Overview The UC Davis-led CYBORGEL project has been awarded up to $36.5 million in ARPA-H funding to pioneer room-temperature storage solutions for cellular therapies. This initiative aims to drastical... -
CAR-T/NK cells: Immunomodulatory expansion and 2026 regulatorys
Frontiers Switzerland Overview A recent academic review details advanced immunomodulatory strategies poised to significantly enhance ex vivo immune cell expansion for adoptive cell therapies, including CAR-T and NK cells. The paper syste... -
OXGENE: Minaris and Asimov AAV cell line manufacturing roadmap
PharmaSource USA Overview Minaris and Asimov have partnered to develop superior producer cell lines for AAV gene therapy manufacturing, combining Minaris' OXGENE viral vector technology with Asimov's synthetic biology platform. This coll... -
I Peace: Clinical-grade iPSC mass production specs for 2026
BioInformant USA Overview I Peace has developed a fully-closed automated manufacturing system capable of mass-producing clinical-grade induced pluripotent stem cell (iPSC) lines, successfully meeting stringent FDA and PMDA safety standar... -
Cell Culture Technology Weekly Report September 20, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report September 20, 2026 (PDF) — Download Weekly Report September 20, 2026 (PDF) — DownloadDownload 🎙 Podcast Septe... -
Lonza Expands US Manufacturing with New Spray Drying Facility; Samsung Biologics Secures $262M European CDMO Deal
Endpoints News Switzerland, South Korea, USA Overview Lonza announced a significant expansion of its U.S. manufacturing capabilities with a new commercial spray drying facility in Bend, Oregon, projected for completion by 2029 and creati... -
Asahi Kasei Bioprocess Launches VANTIJ® SU-VFC Benchtop to Elevate Efficiency and Consistency in Gene Therapy Manufacturing
Asahi Kasei Japan Overview Asahi Kasei Bioprocess has introduced the VANTIJ® SU-VFC Benchtop, a novel small-format, automated, single-use virus filtration system for gene therapy manufacturing. This system is designed to significantly en... -
BIANCA CLINIC Pioneers Regenerative Medicine in Japan with Autologous Adipose Stem Cells and Exosome Therapy under Strict Regulatory Compliance
BIANCA CLINIC Japan Overview BIANCA CLINIC in Tokyo is advancing regenerative medicine by offering exosome therapy, purified stem cell culture supernatant, and autologous adipose-derived stem cell therapy, all strictly compliant with Jap... -
Äio and TFTAK Secure €1.94M for ‘DigiFoundry 2.0’ Project to Accelerate Waste-Derived Microbial Fat Production via AI-Driven Digital Platform
European Biotechnology Estonia Overview Äio and TFTAK have received €1.94 million in funding for their 'DigiFoundry 2.0' project, an AI-driven digital platform aimed at accelerating waste-derived microbial fat production. This three-year...
